BriaCell Therapeutics Corp.
corporate_fare Company Profile
BriaCell Therapeutics Corp. (NASDAQ:BCTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for BCTX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- BriaCell Secures $30M Public Offering at Premium to Market, Bolstering Clinical Pipeline
- BriaCell Therapeutics Announces Highly Dilutive $30M Unit Offering at Deep Discount to Market Price
- BriaCell Therapeutics Registers Additional $11.56M in Securities Offering, Signaling Substantial Dilution
Financial Snapshot
Fiscal year ended July 31, 2026
Net Income
-$34.9M
Diluted EPS
-$6.97
Op. Cash Flow
-$28.65M
Free Cash Flow
-$28.78M
Operating Income
-$36.05M
Cash & Equivalents
$9.85M
Debt / Equity
0.00×
Shares Outstanding
8.71M sh
Source: 10-K · filed 2026-10-28 · accession 0001493152-26-049041
show_chartPrice Chart
Loading chart...
feed BCTX - Filings & News (Page 2)
BCTX
Jan 15, 2026, 4:15 PM EST
Price at Filing:
$4.55
Real-time Price:
$3.10
Change:
-$1.45 (-32%)
Market Cap:
$26.721M
BCTX
Jan 14, 2026, 4:15 PM EST
Price at Filing:
$4.83
Real-time Price:
$3.10
Change:
-$1.73 (-36%)
Market Cap:
$26.721M
BCTX
Jan 13, 2026, 8:57 PM EST
Price at Filing:
$4.88
Real-time Price:
$3.10
Change:
-$1.78 (-36%)
Market Cap:
$26.721M